A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

OBJECTIVES: To assess the efficacy of the interleukin 1 receptor antagonist anakinra in systemic-onset juvenile idiopathic arthritis (SJIA). METHODS: A multicentre, randomised, double-blind, placebo-controlled trial was conducted. The primary objective was to compare the efficacy of a 1-month treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Quartier, Pierre, Allantaz, Florence, Cimaz, Rolando, Pillet, Pascal, Messiaen, Claude, Bardin, Christophe, Bossuyt, Xavier, Boutten, Anne, Bienvenu, Jacques, Duquesne, Agnes, Richer, Olivier, Chaussabel, Damien, Mogenet, Agnes, Banchereau, Jacques, Treluyer, Jean-Marc, Landais, Paul, Pascual, Virginia
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070271/
https://www.ncbi.nlm.nih.gov/pubmed/21173013
http://dx.doi.org/10.1136/ard.2010.134254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070271/
https://www.ncbi.nlm.nih.gov/pubmed/21173013
http://dx.doi.org/10.1136/ard.2010.134254

Ejemplares similares